-
1
Radiation therapy for primary orbital and ocular adnexal lymphoma
Published 2023-01-01Subjects: “…Lymphoma…”
Get full text
Article -
2
Multiple primary malignancies in 788 Chinese patients with diffuse large B‐cell lymphoma
Published 2023-07-01Subjects: “…diffuse large B‐cell lymphoma…”
Get full text
Article -
3
P1214: CTPS1 ACTS AS A PROGNOSTIC BIOMARKER AND THERAPEUTIC TARGET IN MANTLE CELL LYMPHOMA
Published 2023-08-01Get full text
Article -
4
First-Line Autologous Stem Cell Transplantation for Mantle Cell Lymphoma: A Systematic Analysis and Treatment Recommendation
Published 2022-05-01Subjects: “…mantle cell lymphoma…”
Get full text
Article -
5
P1155: MORE PRECISE RISK STRATIFICATION FOR TP53 MUTANT DIFFUSE LARGE B CELL LYMPHOMA
Published 2023-08-01Get full text
Article -
6
-
7
Single‐cell profiling‐guided combination therapy of c‐Fos and histone deacetylase inhibitors in diffuse large B‐cell lymphoma
Published 2022-05-01Subjects: “…diffuse large B‐cell lymphoma…”
Get full text
Article -
8
-
9
-
10
-
11
-
12
Differences in clinical characteristics and outcomes between patients with grade 3a and grades 1–2 follicular lymphoma: a real-world multicenter study
Published 2023-02-01Subjects: “…Follicular lymphoma…”
Get full text
Article -
13
Long‐term outcomes of second‐line versus later‐line zanubrutinib treatment in patients with relapsed/refractory mantle cell lymphoma: An updated pooled analysis
Published 2023-09-01Subjects: “…mantle cell lymphoma…”
Get full text
Article -
14
Initial Treatment Patterns and Survival Outcomes of Mantle Cell Lymphoma Patients Managed at Chinese Academic Centers in the Rituximab Era: A Real-World Study
Published 2022-01-01Subjects: “…mantle cell lymphoma…”
Get full text
Article -
15
-
16
Chinese expert consensus on Bruton tyrosine kinase inhibitors in the treatment of B-cell malignancies
Published 2023-10-01Subjects: Get full text
Article -
17
Safety of a 90-min duration of intravenous infusion of obinutuzumab in patients with B-cell non-Hodgkin's lymphoma in a tertiary hospital in China: a prospective, open-label, exploratory clinical trial
Published 2024-02-01“…This study aimed to analyze the safety and applicability of a 90-min duration of infusion (SDI) of obinutuzumab in patients with B-cell non-Hodgkin's lymphoma (NHL) in a tertiary hospital in China. This exploratory clinical trial was performed at Jiangsu Province Hospital. …”
Get full text
Article -
18
-
19
Spectrum and trigger identification of hemophagocytic lymphohistiocytosis in adults: A single-center analysis of 555 cases
Published 2022-08-01Subjects: Get full text
Article -
20
Deoxynivalenol Induces Caspase-8-Mediated Apoptosis through the Mitochondrial Pathway in Hippocampal Nerve Cells of Piglet
Published 2021-01-01“…Increasing concentrations of DON led to decreased B-cell lymphoma-2 (Bcl-2) expression and increased expression of BCL2-associated X (Bax) and B-cell lymphoma-2 homology 3 interacting domain death agonist (Bid), which in turn increased transcriptional activity of the transcription factors AIF and P53 (a tumor suppressor gene, promotes apoptosis). …”
Get full text
Article